CERo Therapeutics Inc.

NASDAQ: CERO · Real-Time Price · USD
8.42
-2.26 (-21.16%)
At close: Jun 23, 2025, 3:59 PM
8.68
3.09%
After-hours: Jun 23, 2025, 07:59 PM EDT
-21.16%
Bid 6.98
Market Cap 4.35M
Revenue (ttm) n/a
Net Income (ttm) -13.9M
EPS (ttm) -488.69
PE Ratio (ttm) -0.02
Forward PE -0.4
Analyst Buy
Ask 10.49
Volume 1,373,930
Avg. Volume (20D) 1,097,467
Open 11.90
Previous Close 10.68
Day's Range 8.26 - 13.14
52-Week Range 6.71 - 896.00
Beta 0.43

About CERO

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CERO
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CERO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 week ago
+188.65%
CERo Therapeutics shares are trading higher after ... Unlock content with Pro Subscription
2 months ago
+38.84%
CERo Therapeutics Holdings shares are trading higher after the company announced the key clinical trial site location for its Phase 1 CER-1236 trial.